scholarly journals Relationship between skeletal muscle mass and liver fibrosis markers for patients with hepatitis C virus related liver disease

Medicine ◽  
2017 ◽  
Vol 96 (48) ◽  
pp. e8761
Author(s):  
Ryo Takata ◽  
Hiroki Nishikawa ◽  
Hirayuki Enomoto ◽  
Yoshinori Iwata ◽  
Akio Ishii ◽  
...  
Keyword(s):  
Skeletal Muscle ◽  
Hepatitis C Virus ◽  
Liver Disease ◽  
Hepatitis C ◽  
Liver Fibrosis ◽  
Muscle Mass ◽  
Skeletal Muscle Mass ◽  
Related Liver Disease

Skeletal muscle mass depletion in patients with hepatitis C virus infection

2019 ◽  
Vol 31 (1) ◽  
pp. 59-66 ◽  
Author(s):  
Aiko Fukui ◽  
Naoto Kawabe ◽  
Senju Hashimoto ◽  
Hiroyuki Kamei ◽  
Kentaro Yoshioka
Keyword(s):  
Skeletal Muscle ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Muscle Mass ◽  
Skeletal Muscle Mass ◽  
Hepatitis C Virus Infection ◽  
Mass Depletion

scholarly journals Improvement of Skeletal Muscle Mass after Ledipasvir and Sofosbuvir Treatment for Hepatitis C Virus in Decompensated Liver Cirrhosis

2021 ◽  
Vol 60 (5) ◽  
pp. 745-750
Author(s):  
Ryotaro Sakamori ◽  
Ryoko Yamada ◽  
Kazuma Shinkai ◽  
Akira Doi ◽  
Yuki Tahata ◽  
...  
Keyword(s):  
Skeletal Muscle ◽  
Liver Cirrhosis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Muscle Mass ◽  
Skeletal Muscle Mass ◽  
Decompensated Liver Cirrhosis

scholarly journals Relationship between Muscle Mass and Non-Alcoholic Fatty Liver Disease

Biology ◽  
2021 ◽  
Vol 10 (2) ◽  
pp. 122
Author(s):  
Jun-Hyuk Lee ◽  
Hye-Sun Lee ◽  
Byoung-Kwon Lee ◽  
Yu-Jin Kwon ◽  
Ji-Won Lee
Keyword(s):  
Skeletal Muscle ◽  
Risk Factor ◽  
Liver Disease ◽  
Fatty Liver ◽  
Muscle Mass ◽  
Fatty Liver Disease ◽  
Skeletal Muscle Mass ◽  
Liver Fat ◽  
Alcoholic Fatty Liver ◽  
Alcoholic Fatty Liver Disease

Although sarcopenia is known to be a risk factor for non-alcoholic fatty liver disease (NAFLD), whether NAFLD is a risk factor for the development of sarcopenia is not clear. We investigated relationships between NAFLD and low skeletal muscle mass index (LSMI) using three different datasets. Participants were classified into LSMI and normal groups. LSMI was defined as a body mass index (BMI)-adjusted appendicular skeletal muscle mass <0.789 in men and <0.512 in women or as the sex-specific lowest quintile of BMI-adjusted total skeletal muscle mass. NAFLD was determined according to NAFLD liver fat score or abdominal ultrasonography. The NAFLD groups showed a higher hazard ratios (HRs) with 95% confidence intervals (CIs) for LSMI than the normal groups (HRs = 1.21, 95% CIs = 1.05–1.40). The LSMI groups also showed a higher HRs with 95% CIs for NAFLD than normal groups (HRs = 1.56, 95% CIs = 1.38–1.78). Participants with NAFLD had consistently less skeletal muscle mass over 12 years of follow-up. In conclusion, LSMI and NAFLD showed a relationship. Maintaining muscle mass should be emphasized in the management of NAFLD.

Sign in / Sign up

Export Citation Format

Share Document